Schedule 1 includes drugs that are dangerous, addictive, and without any medical merit.

The DEA needs to justify its budgetary funding, and the FDA prefers rubber stamp approving pharmaceutical drugs that are far more dangerous than marijuana and far less effective.

The unpublicized studies that prove cannabis’s medical merits are referenced within the NCI (National Cancer Institute). Though they are pre-utical drugs to enhance chemo or suppress some of the chemotherapy’s terrible side effects, there are many actual case histories of curing cancers with cannabis.

People who are cured by cannabis doesn’t satisfy medical “Science”.

Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow.

Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.

A study in mice showed that cannabinoids may protect against inflammation of the colon and may have potential in reducing the risk of colon cancer, and possibly in its treatment.

A laboratory study of delta-9-THC in hepatocellular carcinoma cells showed that it damaged or killed the cancer cells.

The same study of delta-9-THC in mouse models of liver cancer showed that it had antitumor effects.

Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found in non-small cell lung cancer cells and breast cancer cells.

A laboratory study of cannabidiol in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells.

Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.

A laboratory study of cannabidiol in human glioma cells showed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells.

Studies in mouse models of cancer showed that CBD together with delta-9-THC may make chemotherapy such as temozolomide more effective.

Many animal studies have shown that delta-9-THC and other cannabinoids stimulate appetite and can increase food intake.

Cannabinoid receptors have been studied in the brain, spinal cord, and nerve endings throughout the body to understand their roles in pain relief.

Cannabinoids have been studied for anti-inflammatory effects that may play a role in pain relief.

End of excerpt from the National Cancer Institute, the “Government’s primary cancer research agency”.

Paradoxically, another government agency that’s supposed to protect us, the FDA, has recently approved the most dangerous painkiller Oxycontin for 11-year-old children.

Evidently the studies listed by the NCI don’t indicate medical merit, but less effective, side-effect-laden synthetic derivatives of cannabis that Big Pharma creates are FDA approved – Ka-ching!

Of course, also ignored are the several animal and human trials conducted on cannabis for various diseases, including cancer, in Spain and Israel.

 

 

Source